艾昆纬-MRD作为多发性骨髓瘤加速批准的主要终点.pdf

艾昆纬-MRD作为多发性骨髓瘤加速批准的主要终点.pdf

WhitePaper

InsightsintoClinicalTrial

EnrollmentforMASHwith

CompensatedCirrhosis

MARKDELEGGE,MD,SeniorMedicalDirector,Head,GastroenterologyCenterofExcellence

MARGARETHTERADA,PharmD,AssociateDirector,TherapeuticAnalyticsLead

Tableofcontents

Executivesummary

文档评论(0)

1亿VIP精品文档

相关文档